Mirum Pharmaceuticals (MIRM) Cash from Operations (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Mirum Pharmaceuticals | 5.97 Bn | 5.59 Bn | 131.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,870.61% |
| Dec 31, 2025 | -84.71% |
| Sep 30, 2025 | 229.58% |
| Jun 30, 2025 | 713.97% |
| Mar 31, 2025 | 61.31% |
| Dec 31, 2024 | -227.21% |
| Sep 30, 2024 | 204.76% |
| Jun 30, 2024 | -125.00% |
| Mar 31, 2024 | 191.54% |
| Dec 31, 2023 | 8.80% |
| Sep 30, 2023 | -5.14% |
| Jun 30, 2023 | 7.69% |
| Mar 31, 2023 | 45.22% |
| Dec 31, 2022 | -31.68% |
| Sep 30, 2022 | -29.02% |
| Jun 30, 2022 | 49.15% |
| Mar 31, 2022 | -19.68% |
| Dec 31, 2021 | 3.08% |
| Sep 30, 2021 | 14.92% |
| Jun 30, 2021 | -59.46% |
| Mar 31, 2021 | 30.51% |
| Dec 31, 2020 | -107.89% |
| Sep 30, 2020 | -2.69% |
| Jun 30, 2020 | 7.39% |
| Mar 31, 2020 | -33.97% |
| Dec 31, 2019 | 10.01% |
| Sep 30, 2019 | -89.86% |
| Jun 30, 2019 | -230.46% |